These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9708179)

  • 1. V beta 11+ T-lymphocyte expansion by toxic shock syndrome toxin-1 differs in mice bearing H-2q versus H-2b haplotypes.
    Zhao YX; Brunsberg U; Holmdahl R; Tarkowski A
    Immunology; 1998 May; 94(1):1-4. PubMed ID: 9708179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
    Dennig D; Yan Y; Ferguson K; O'Reilly RJ
    Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal expansion of T lymphocytes causes arthritis and mortality in mice infected with toxic shock syndrome toxin-1-producing staphylococci.
    Abdelnour A; Bremell T; Holmdahl R; Tarkowski A
    Eur J Immunol; 1994 May; 24(5):1161-6. PubMed ID: 8181526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V beta gene expansion.
    Jackow CM; Cather JC; Hearne V; Asano AT; Musser JM; Duvic M
    Blood; 1997 Jan; 89(1):32-40. PubMed ID: 8978274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules.
    Uchiyama T; Tadakuma T; Imanishi K; Araake M; Saito S; Yan XJ; Fujikawa H; Igarashi H; Yamaura N
    J Immunol; 1989 Nov; 143(10):3175-82. PubMed ID: 2509554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staphylococcus aureus superantigens elicit redundant and extensive human Vbeta patterns.
    Thomas D; Dauwalder O; Brun V; Badiou C; Ferry T; Etienne J; Vandenesch F; Lina G
    Infect Immun; 2009 May; 77(5):2043-50. PubMed ID: 19255190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of toxic shock syndrome toxin-1 to murine major histocompatibility complex class II molecules.
    Scholl PR; Sekaly RP; Diez A; Glimcher LH; Geha RS
    Eur J Immunol; 1990 Sep; 20(9):1911-6. PubMed ID: 2209697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig.
    Saha B; Jaklic B; Harlan DM; Gray GS; June CH; Abe R
    J Immunol; 1996 Nov; 157(9):3869-75. PubMed ID: 8892617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.
    Brogan PA; Shah V; Klein N; Dillon MJ
    Arthritis Rheum; 2004 Feb; 50(2):589-97. PubMed ID: 14872503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for differential binding of staphylococcal enterotoxin A and toxic shock syndrome toxin 1 to class II major histocompatibility molecules.
    Pontzer CH; Russell JK; Johnson HM
    Proc Natl Acad Sci U S A; 1991 Jan; 88(1):125-8. PubMed ID: 1986357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of MHC class II-associated peptides that promote the presentation of toxic shock syndrome toxin-1 to T cells.
    Hogan RJ; VanBeek J; Broussard DR; Surman SL; Woodland DL
    J Immunol; 2001 Jun; 166(11):6514-22. PubMed ID: 11359802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of superantigens on human thymocytes: selective proliferation of V beta 2+ cells in response to toxic shock syndrome toxin-1 and their deletion upon secondary stimulation.
    Mingari MC; Cambiaggi A; Vitale C; Schiavetti F; Bellomo R; Poggi A
    Int Immunol; 1996 Feb; 8(2):203-9. PubMed ID: 8671605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staphylococcal enterotoxin B induces an early and transient state of immunosuppression characterized by V beta-unrestricted T cell unresponsiveness and defective antigen-presenting cell functions.
    Muraille E; De Smedt T; Andris F; Pajak B; Armant M; Urbain J; Moser M; Leo O
    J Immunol; 1997 Mar; 158(6):2638-47. PubMed ID: 9058796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of site-specific monoclonal antibodies directed to toxic shock syndrome toxin-1 in experimental Staphylococcus aureus arthritis.
    Verdrengh M; Kum W; Chow A; Tarkowski A
    Clin Exp Immunol; 1999 Nov; 118(2):268-70. PubMed ID: 10540189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. V beta specificity of superantigen TSST-1 plus CD28 costimulation without APCs.
    Hu WG; Zhu XH
    Immunol Invest; 1996; 25(5-6):405-11. PubMed ID: 8915678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen.
    Kuroda K; Yagi J; Imanishi K; Yan XJ; Li XY; Fujimaki W; Kato H; Miyoshi-Akiyama T; Kumazawa Y; Abe H; Uchiyama T
    J Immunol; 1996 Aug; 157(4):1422-31. PubMed ID: 8759722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1.
    Rukkawattanakul T; Sookrung N; Seesuay W; Onlamoon N; Diraphat P; Chaicumpa W; Indrawattana N
    Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of interferon-gamma mRNA expression in toxic shock syndrome toxin-1 expanded V beta 11+ T lymphocytes.
    Zhao YX; Abdelnour A; Ljungdahl A; Olsson T; Tarkowski A
    Cell Immunol; 1995 Mar; 161(1):28-33. PubMed ID: 7867082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular requirements for T cell activation by the staphylococcal toxic shock syndrome toxin-1.
    Norton SD; Schlievert PM; Novick RP; Jenkins MK
    J Immunol; 1990 Mar; 144(6):2089-95. PubMed ID: 2313089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
    Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M
    J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.